Selected:
![](https://www.eecs.mit.edu/wp-content/uploads/2024/02/MIT-Traverso-Giovanni-01-Press_0-750x475.jpg)
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.